| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adjuvant chemotherapy in lobular carcinoma of the breast: a clinicopathological score identifies high-risk patient with survival benefit
|
Nonneville, Alexandre de
|
|
2019
|
175 |
2 |
p. 379-387
|
artikel
|
| 2 |
A high-risk luminal A dominant breast cancer subtype with increased mobility
|
Guo, Liping
|
|
2019
|
175 |
2 |
p. 459-472
|
artikel
|
| 3 |
Anti-tumor and anti-metastasis efficacy of E6201, a MEK1 inhibitor, in preclinical models of triple-negative breast cancer
|
Lee, Jangsoon
|
|
2019
|
175 |
2 |
p. 339-351
|
artikel
|
| 4 |
Breast sensibility after mastectomy and implant-based breast reconstruction
|
Bijkerk, E.
|
|
2019
|
175 |
2 |
p. 369-378
|
artikel
|
| 5 |
Clinical implementation of pre-treatment DPYD genotyping in capecitabine-treated metastatic breast cancer patients
|
Stavraka, Chara
|
|
2019
|
175 |
2 |
p. 511-517
|
artikel
|
| 6 |
Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach
|
Leal, Mariana Ferreira
|
|
2019
|
175 |
2 |
p. 317-326
|
artikel
|
| 7 |
Corneal features in trastuzumab emtansine treatment: not a rare occurrence
|
Deklerck, Els
|
|
2019
|
175 |
2 |
p. 525-530
|
artikel
|
| 8 |
ERα upregulates the expression of long non-coding RNA LINC00472 which suppresses the phosphorylation of NF-κB in breast cancer
|
Wang, Zhanwei
|
|
2019
|
175 |
2 |
p. 353-368
|
artikel
|
| 9 |
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion
|
Kamdem, Landry K.
|
|
2019
|
175 |
2 |
p. 297-303
|
artikel
|
| 10 |
Extent of resection and role of adjuvant treatment in resected localized breast angiosarcoma
|
McClelland, Shearwood
|
|
2019
|
175 |
2 |
p. 409-418
|
artikel
|
| 11 |
Germline TP53 mutation spectrum in Sudanese premenopausal breast cancer patients: correlations with reproductive factors
|
Aceto, Gitana Maria
|
|
2019
|
175 |
2 |
p. 479-485
|
artikel
|
| 12 |
Health-related quality of life in long-term disease-free breast cancer survivors versus female population controls in Germany
|
Doege, Daniela
|
|
2019
|
175 |
2 |
p. 499-510
|
artikel
|
| 13 |
Hormone- and HER2-receptor assessment in 33,046 breast cancer patients: a nationwide comparison of positivity rates between pathology laboratories in the Netherlands
|
Dooijeweert, Carmen van
|
|
2019
|
175 |
2 |
p. 487-497
|
artikel
|
| 14 |
Loss of HER2 after HER2-targeted treatment
|
Ignatov, Tanja
|
|
2019
|
175 |
2 |
p. 401-408
|
artikel
|
| 15 |
Oophorectomy and risk of contralateral breast cancer among BRCA1 and BRCA2 mutation carriers
|
Kotsopoulos, Joanne
|
|
2019
|
175 |
2 |
p. 443-449
|
artikel
|
| 16 |
Real-world data on discordance between estrogen, progesterone, and HER2 receptor expression on diagnostic tumor biopsy versus tumor resection material
|
Berghuis, A. M. Sofie
|
|
2019
|
175 |
2 |
p. 451-458
|
artikel
|
| 17 |
Screening for distant metastases in patients with ipsilateral breast tumor recurrence: the impact of different imaging modalities on distant recurrence-free interval
|
Poodt, Ingrid G. M.
|
|
2019
|
175 |
2 |
p. 419-428
|
artikel
|
| 18 |
SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma
|
Bossart, Emily A.
|
|
2019
|
175 |
2 |
p. 327-337
|
artikel
|
| 19 |
Strong impact of MammaPrint and BluePrint on treatment decisions in luminal early breast cancer: results of the WSG-PRIMe study
|
Wuerstlein, R.
|
|
2019
|
175 |
2 |
p. 389-399
|
artikel
|
| 20 |
Systemic treatment and radiotherapy, breast cancer subtypes, and survival after long-term clinical follow-up
|
Yang, Sherry X.
|
|
2019
|
175 |
2 |
p. 287-295
|
artikel
|
| 21 |
The effect of chemotherapy on subjective cognitive function in younger early-stage breast cancer survivors treated with chemotherapy compared to older patients
|
Gregorowitsch, M. L.
|
|
2019
|
175 |
2 |
p. 429-441
|
artikel
|
| 22 |
The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review
|
Marks, Dustin H.
|
|
2019
|
175 |
2 |
p. 267-276
|
artikel
|
| 23 |
The estrogen receptor coactivator AIB1 is a new putative prognostic biomarker in ER-positive/HER2-negative invasive lobular carcinoma of the breast
|
Narbe, Ulrik
|
|
2019
|
175 |
2 |
p. 305-316
|
artikel
|
| 24 |
The next generation personalized models to screen hidden layers of breast cancer tumorigenicity
|
Afzali, F.
|
|
2019
|
175 |
2 |
p. 277-286
|
artikel
|
| 25 |
Trends in utilization of hypofractionated whole breast irradiation (HF-WBI) in triple negative breast cancer (TNBC): a national cancer database (NCDB) analysis
|
Rice, Stephanie R.
|
|
2019
|
175 |
2 |
p. 473-478
|
artikel
|
| 26 |
Validation of the breast cancer surveillance consortium model of breast cancer risk
|
Tice, Jeffrey A.
|
|
2019
|
175 |
2 |
p. 519-523
|
artikel
|
Tijdschrift beschrijving